Literature DB >> 17300756

Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia.

James L Reilly1, Margret S H Harris, Tin T Khine, Matcheri S Keshavan, John A Sweeney.   

Abstract

BACKGROUND: This study sought to replicate previous findings of worsened performance on a translational spatial working memory task among antipsychotic-naïve first-episode schizophrenia patients after antipsychotic treatment and to extend these findings by examining whether changes in the allocation of covert attention contribute to this effect.
METHODS: Fourteen antipsychotic-naïve schizophrenia patients performed an oculomotor delayed response task before and 6 weeks after antipsychotic treatment (risperidone n = 11; olanzapine n = 3). Fifteen matched healthy individuals were studied in parallel.
RESULTS: Patients' pretreatment deficit in accurately remembering spatial locations was exacerbated by antipsychotic treatment, consistent with previous findings; however, this occurred only when covert attention was directed away from remembered locations during delay periods.
CONCLUSIONS: Disruption in the allocation of covert attention might contribute to patients' decline in spatial working memory after antipsychotic treatment. Alterations in prefrontal dopaminergic systems or reduced thalamocortical drive might account for this apparent adverse cognitive effect of antipsychotic treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17300756     DOI: 10.1016/j.biopsych.2006.10.031

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  26 in total

Review 1.  Classifying antipsychotic agents : need for new terminology.

Authors:  Ripu D Jindal; Matcheri S Keshavan
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

2.  Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.

Authors:  S Kristian Hill; Alison Buchholz; Hayley Amsbaugh; James L Reilly; Leah H Rubin; James M Gold; Richard S E Keefe; Godfrey D Pearlson; Matcheri S Keshavan; Carol A Tamminga; John A Sweeney
Journal:  Schizophr Res       Date:  2015-05-23       Impact factor: 4.939

3.  Differential effects of paced and unpaced responding on delayed serial order recall in schizophrenia.

Authors:  S Kristian Hill; Ginny B Griffin; James C Houk; John A Sweeney
Journal:  Schizophr Res       Date:  2011-06-25       Impact factor: 4.939

4.  Disease and drug effects on internally-generated and externally-elicited responses in first episode schizophrenia and psychotic bipolar disorder.

Authors:  Sarah K Keedy; Jeffrey R Bishop; Peter J Weiden; John A Sweeney; Cherise Rosen; Robert Marvin; James L Reilly
Journal:  Schizophr Res       Date:  2014-08-08       Impact factor: 4.939

5.  Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia.

Authors:  Sarah K Keedy; James L Reilly; Jeffrey R Bishop; Peter J Weiden; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-06-03       Impact factor: 9.306

Review 6.  Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.

Authors:  Daniel J Foster; P Jeffrey Conn
Journal:  Neuron       Date:  2017-05-03       Impact factor: 17.173

7.  Salience of working-memory maintenance and manipulation deficits in schizophrenia.

Authors:  S K Hill; G B Griffin; T Kazuto Miura; E S Herbener; J A Sweeney
Journal:  Psychol Med       Date:  2010-03-10       Impact factor: 7.723

8.  Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.

Authors:  Jeffrey R Bishop; James L Reilly; Margret S H Harris; Shitalben R Patel; Rick Kittles; Judith A Badner; Konasale M Prasad; Vishwajit L Nimgaonkar; Matcheri S Keshavan; John A Sweeney
Journal:  Psychopharmacology (Berl)       Date:  2014-08-07       Impact factor: 4.530

9.  The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study in individuals with schizophrenia.

Authors:  Gabriel Selva-Vera; Vicent Balanzá-Martínez; José Salazar-Fraile; José Sánchez-Moreno; Anabel Martinez-Aran; Patricia Correa; Eduard Vieta; Rafael Tabarés-Seisdedos
Journal:  BMC Psychiatry       Date:  2010-06-15       Impact factor: 3.630

Review 10.  Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.

Authors:  James L Reilly; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-02-26       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.